Leucoféresis terapeútica para hiperleucocitosis en leucemia mieloide crónica

Therapeutic lukopheresis for hyperleukocytosis in chronic myeloid leukemia

Authors

  • José Luis Huerto Aguilar Servicio de Hematología, Hemoterapia y Banco de Sangre, Hospital Nacional Alberto Sabogal Sologuren. Callao, Perú. Médico Cirujano, especialista en Patología Clínica. https://orcid.org/0000-0002-5235-4439
  • Adrián Martín Villaorduña Ñahuis Servicio de Hematología, Hemoterapia y Banco de Sangre, Hospital Nacional Alberto Sabogal Sologuren. Callao, Perú. Médico Cirujano, especialista en Patología Clínica. https://orcid.org/0000-0001-5109-6418

DOI:

https://doi.org/10.17268/rmt.2024.v19i1.5023

Keywords:

hyperleukocytosis, leukopheresis, myeloid leukemia

Abstract

Chronic myeloid leukemia usually presents nonspecific symptomatology, but clinical signs of hyperleukocytosis appear when it progresses to the acute phase. We present a case of hyperleukocytosis associated with acute phase chronic myeloid leukemia that responds to treatment with leukopheresis. The use of this procedure is recommended to reduce symptomatology, but not as definitive treatment of the disease.

Published

2024-03-29

How to Cite

1.
Huerto Aguilar JL, Villaorduña Ñahuis AM. Leucoféresis terapeútica para hiperleucocitosis en leucemia mieloide crónica: Therapeutic lukopheresis for hyperleukocytosis in chronic myeloid leukemia. Rev Med Trujillo [Internet]. 2024Mar.29 [cited 2024Jul.3];19(1):031-5. Available from: https://revistas.unitru.edu.pe/index.php/RMT/article/view/5023